“More than 75% of the increase in Comirnaty’s revenue in the third quarter of 2021 comes from countries outside the United States,” said Pfizer CEO Albert Bourla in the company’s quarterly results statement.
“We are on track to meet our goal of supplying at least 2 billion doses to low- and middle-income countries by the end of 2022,” he added, noting that half of these doses would be sold to the US government at cost price for its distribution in the poorest countries of the world. In the year as a whole, Pfizer plans to supply 2.3 billion vaccines worldwide.
In late October, the U.S. Food and Drug Administration (FDA) approved Comirnaty for children ages 5 to 11, paving the way for a major new vaccination campaign in the country.
A group of experts from the Centers for Disease Control and Prevention (CDC) is meeting Tuesday to decide whether the vaccine is recommended for younger children. From July to September, Pfizer posted sales of $ 24.1 billion, more than the 22.7 billion expected by Wall Street. The group’s net profit in the period was US $ 8.150 million.
Source From: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
